1
|
Habrowska-Górczyńska DE, Kowalska K, Urbanek KA, Domińska K, Kozieł MJ, Piastowska-Ciesielska AW. Effect of the mycotoxin deoxynivalenol in combinational therapy with TRAIL on prostate cancer cells. Toxicol Appl Pharmacol 2023; 461:116390. [PMID: 36690084 DOI: 10.1016/j.taap.2023.116390] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2022] [Revised: 01/17/2023] [Accepted: 01/18/2023] [Indexed: 01/22/2023]
Abstract
Tumor necrosis factor-related apoptosis-induced ligand (TRAIL) is reported as a promising anti-cancer therapeutic target. Unfortunately, prostate cancer cells (PCa) are partially resistant to TRAIL-induced apoptosis limiting its therapeutic potential. The existing body of knowledge suggests that naturally produced compounds, such as mycotoxin deoxynivalenol (DON), might potentially sensitize cells to TRAIL treatment and improve the efficiency of therapy. Previously, we observed that DON induces oxidative stress and apoptosis in PCa cell lines. Thus we addressed here whether DON can sensitize PCa cells to TRAIL-induced apoptosis. Our data demonstrates that three out of four tested PCa cell lines pretreated with DON increased TRAIL-induced apoptosis detected with flow cytometry. This effect was associated with oxidative stress (LNCaP and DU-145 cell line) and elevated DNA damage (DU-145, LNCaP, and 22Rv1 cell lines). Next, in the animal model we inoculated PC tumor to SCKID mice followed by administration of DON intraperitoneally and/or TRIAL intravenously. During 21 days monitoring of tumor growth, the animals received 7 doses of DON, TRAIL, DON+TRAIL or control injections. No significant reduction in tumor mass was observed after combinational treatment of TRAIL and DON compared to 1 μg/kg of body weight DON treatment alone, which itself decreased the tumor growth. However, despite the lack of the TRAIL + DON effect, DON itself inducing apoptosis is an interesting compound worth investigating in the context of other combination therapies.
Collapse
Affiliation(s)
| | - Karolina Kowalska
- Department of Cell Cultures and Genomic Analysis, Medical University of Lodz, Zeligowskiego 7/9, Lodz 90-752, Poland
| | - Kinga Anna Urbanek
- Department of Cell Cultures and Genomic Analysis, Medical University of Lodz, Zeligowskiego 7/9, Lodz 90-752, Poland
| | - Kamila Domińska
- Department of Comparative Endocrinology, Medical University of Lodz, Zeligowskiego 7/9, Lodz 90-752, Poland
| | - Marta Justyna Kozieł
- Department of Cell Cultures and Genomic Analysis, Medical University of Lodz, Zeligowskiego 7/9, Lodz 90-752, Poland
| | | |
Collapse
|
2
|
Novel 7-Chloro-(4-thioalkylquinoline) Derivatives: Synthesis and Antiproliferative Activity through Inducing Apoptosis and DNA/RNA Damage. Pharmaceuticals (Basel) 2022; 15:ph15101234. [PMID: 36297346 PMCID: PMC9607427 DOI: 10.3390/ph15101234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2022] [Revised: 09/30/2022] [Accepted: 10/04/2022] [Indexed: 11/29/2022] Open
Abstract
A series of 78 synthetic 7-chloro-(4-thioalkylquinoline) derivatives were investigated for cytotoxic activity against eight human cancer as well as 4 non-tumor cell lines. The results showed, with some exceptions, that sulfanyl 5-40 and sulfinyl 41-62 derivatives exhibited lower cytotoxicity for cancer cell lines than those of well-described sulfonyl N-oxide derivatives 63-82. As for compound 81, the most pronounced selectivity (compared against BJ and MRC-5 cells) was observed for human cancer cells from HCT116 (human colorectal cancer with wild-type p53) and HCT116p53-/- (human colorectal cancer with deleted p53), as well as leukemia cell lines (CCRF-CEM, CEM-DNR, K562, and K562-TAX), lung (A549), and osteosarcoma cells (U2OS). A good selectivity was also detected for compounds 73 and 74 for leukemic and colorectal (with and without p53 deletion) cancer cells (compared to MRC-5). At higher concentrations (5 × IC50) against the CCRF-CEM cancer cell line, we observe the accumulation of the cells in the G0/G1 cell phase, inhibition of DNA and RNA synthesis, and induction of apoptosis. In addition, X-ray data for compound 15 is being reported. These results provide useful scientific data for the development of 4-thioalkylquinoline derivatives as a new class of anticancer candidates.
Collapse
|
3
|
Van de Walle T, Cools L, Mangelinckx S, D'hooghe M. Recent contributions of quinolines to antimalarial and anticancer drug discovery research. Eur J Med Chem 2021; 226:113865. [PMID: 34655985 DOI: 10.1016/j.ejmech.2021.113865] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2021] [Revised: 09/01/2021] [Accepted: 09/20/2021] [Indexed: 12/28/2022]
Abstract
Quinoline, a privileged scaffold in medicinal chemistry, has always been associated with a multitude of biological activities. Especially in antimalarial and anticancer research, quinoline played (and still plays) a central role, giving rise to the development of an array of quinoline-containing pharmaceuticals in these therapeutic areas. However, both diseases still affect millions of people every year, pointing to the necessity of new therapies. Quinolines have a long-standing history as antimalarial agents, but established quinoline-containing antimalarial drugs are now facing widespread resistance of the Plasmodium parasite. Nevertheless, as evidenced by a massive number of recent literature contributions, they are still of great value for future developments in this field. On the other hand, the number of currently approved anticancer drugs containing a quinoline scaffold are limited, but a strong increase and interest in quinoline compounds as potential anticancer agents can be seen in the last few years. In this review, a literature overview of recent contributions made by quinoline-containing compounds as potent antimalarial or anticancer agents is provided, covering publications between 2018 and 2020.
Collapse
Affiliation(s)
- Tim Van de Walle
- SynBioC Research Group, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, B-9000, Ghent, Belgium
| | - Lore Cools
- SynBioC Research Group, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, B-9000, Ghent, Belgium
| | - Sven Mangelinckx
- SynBioC Research Group, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, B-9000, Ghent, Belgium
| | - Matthias D'hooghe
- SynBioC Research Group, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, B-9000, Ghent, Belgium.
| |
Collapse
|
4
|
Ramírez H, Charris K, Fernandez-Moreira E, Nogueda-Torres B, Capparelli MV, Ángel J, Charris J. One-Pot Multicomponent Synthesis of Methoxybenzo[ h]quinoline-3-carbonitrile Derivatives; Anti-Chagas, X-ray, and In Silico ADME/Tox Profiling Studies. Molecules 2021; 26:molecules26226977. [PMID: 34834070 PMCID: PMC8619670 DOI: 10.3390/molecules26226977] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2021] [Revised: 11/04/2021] [Accepted: 11/15/2021] [Indexed: 11/28/2022] Open
Abstract
Several methoxybenzo[h]quinoline-3-carbonitrile analogs were designed and synthesized in a repositioning approach to developing compounds with anti-prostate cancer and anti-Chagas disease properties. The compounds were synthesized through a sequential multicomponent reaction of aromatic aldehydes, malononitrile, and 1-tetralone in the presence of ammonium acetate and acetic acid (catalytic). The effect of the one-pot method on the generation of the target product has been studied. The compounds were in vitro screened against bloodstream trypomastigotes of T. cruzi (NINOA and INC-5 strains) and were most effective at showing a better activity profile than nifurtimox and benznidazole (reference drugs). A study in silico on absorption, distribution, metabolism, excretion, and toxicity (ADME/Tox) profiling to help describe the molecular properties related to the pharmacokinetic aspects in the human body of these compounds was reported. In addition, X-ray data for the compound 2-Amino-5,6-dihydro-4-(3-hydroxy-4-methoxy-phenyl)-8-methoxybenzo[h]quinoline-3-carbonitrile 6 was being reported. Spectral (IR, NMR, and elemental analyses) data on all final compounds were consistent with the proposed structures.
Collapse
Affiliation(s)
- Hegira Ramírez
- Laboratorio de Síntesis Orgánica, Facultad de Farmacia, Universidad Central de Venezuela, Apartado 47206, Los Chaguaramos, Caracas 1041-A, Venezuela;
- Facultad de Medicina, Universidad de Las Américas, Quito 170503, Ecuador
- Correspondence: (H.R.); (J.C.); Tel.: +593-97-8706334 (H.R.); +58-412-2359228 (J.C.)
| | - Katiuska Charris
- Laboratorio de Síntesis Orgánica, Facultad de Farmacia, Universidad Central de Venezuela, Apartado 47206, Los Chaguaramos, Caracas 1041-A, Venezuela;
| | | | - Benjamín Nogueda-Torres
- Escuela Nacional de Ciencias Biológicas, Departamento de Parasitología, Instituto Politécnico Nacional, Mexico City 11340, Mexico;
| | - Mario V. Capparelli
- Unidad de Estructura Molecular, Fundación Instituto de Estudios Avanzados (IDEA), Apartado 17606, Caracas 1015-A, Venezuela;
| | - Jorge Ángel
- Laboratorio de Síntesis Orgánica y Diseño de Fármacos, Dpto. de Química, Facultad Experimental de Ciencias, Universidad del Zulia, Maracaibo 4011-A, Venezuela;
| | - Jaime Charris
- Laboratorio de Síntesis Orgánica, Facultad de Farmacia, Universidad Central de Venezuela, Apartado 47206, Los Chaguaramos, Caracas 1041-A, Venezuela;
- Correspondence: (H.R.); (J.C.); Tel.: +593-97-8706334 (H.R.); +58-412-2359228 (J.C.)
| |
Collapse
|
5
|
Blanco Z, Mijares MR, Ramírez H, Fernandez-Moreira E, Oviedo HJ, Rodríguez NM, Charris JE. In vitro evaluation and in vivo efficacy of nitroimidazole-sulfanyl ethyl derivatives against Leishmania (V.) braziliensis and Leishmania (L.) mexicana. Parasitol Res 2021; 120:3307-3317. [PMID: 34370070 DOI: 10.1007/s00436-021-07266-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2021] [Accepted: 07/21/2021] [Indexed: 11/24/2022]
Abstract
The aim of this study was to synthesize several small molecules of the type 5-nitroimidazole-sulfanyl and evaluate biological properties against the main Leishmania species that cause cutaneous leishmaniasis in Venezuela. Final compounds 4-7 were generated through simple nucleophilic substitution of 1-(2-chloroethyl)-2-methyl-5-nitroimidazole 3 with 2-mercaptoethanol, 1-methyl-2-mercaptoethanol, and 2-thyolacetic acid derivative. Compound 8 was synthesized via a coupling reaction between 7 and (S)-Methyl 2-amino-4-methylpentanoate hydrochloride. The inhibitory concentrations of (3, 4, 7, 8) against Leishmania (L.) mexicana and (V.) braziliensis in promastigotes and experimentally infected macrophages were determined by in vitro activity assays. Compounds 7 and 8 shown high activity against both species of Leishmania and were selected for the in vivo evaluation. Animals were infected with promastigotes of the two species and divided into four groups of ten (10) animals and a control group. Intralesional injection way was used for the treatment. The parasitological diagnostic after treatment was obtained by PCR using species specific oligonucleotides. The two Leishmania species were susceptible to compounds 7 and 8 in vivo assays. The results indicated that both compounds reduce significantly (96%) the size of the lesion and cure 63% of the mice infected with L (L) mexicana or L (V) braziliensis as was determined by PCR. The results are indicating that both compounds may represent an alternative treatment for these two Leishmania species.
Collapse
Affiliation(s)
- Zuleima Blanco
- Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Los Chaguaramos 1041-A, Caracas, 47206, Venezuela
| | - Michael R Mijares
- Biotechnology Unit, Faculty of Pharmacy, Central University of Venezuela, Los Chaguaramos 1041-A, Caracas, 47206, Venezuela
| | - Hegira Ramírez
- Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Los Chaguaramos 1041-A, Caracas, 47206, Venezuela.,Facultad de Medicina, Universidad de Las Américas, Quito, Ecuador
| | | | - Henry J Oviedo
- Institute of Biomedicine, Faculty of Medicine, Central University of Venezuela, 1010-A, 4043, Caracas, Venezuela
| | - Noris M Rodríguez
- Institute of Biomedicine, Faculty of Medicine, Central University of Venezuela, 1010-A, 4043, Caracas, Venezuela
| | - Jaime E Charris
- Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Los Chaguaramos 1041-A, Caracas, 47206, Venezuela.
| |
Collapse
|
6
|
Charris KE, Rodrigues JR, Ramírez H, Fernandez-Moreira E, Ángel JE, Charris JE. Synthesis of 5H-indeno[1,2-b]pyridine derivatives: Antiproliferative and antimetastatic activities against two human prostate cancer cell lines. Arch Pharm (Weinheim) 2021; 354:e2100092. [PMID: 33928662 DOI: 10.1002/ardp.202100092] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2021] [Revised: 04/04/2021] [Accepted: 04/06/2021] [Indexed: 12/18/2022]
Abstract
This study describes the direct synthesis of 2-amino-4-(phenylsubstituted)-5H-indeno[1,2-b]pyridine-3-carbonitrile derivatives 5-21, through sequential multicomponent reaction of aromatic aldehydes, malononitrile, and 1-indanone in the presence of ammonium acetate and acetic acid (catalytic). The biological study showed that compound 10 significantly impeded proliferation of the cell lines PC-3, LNCaP, and MatLyLu. The antimetastatic effects of compound 10 could be related with inhibition of MMP9 in the PC-3 and LNCaP human cell lines. On the basis of a study of the structure-activity relationship of these compounds, we propose that the presence of two methoxy groups at positions 6 and 7 of the indeno nucleus and a 4-hydroxy-3-methoxy phenyl substitution pattern at position 4 of the pyridine ring is decisive for these types of molecules to exert very good antiproliferative and antimetastatic activities.
Collapse
Affiliation(s)
- Katiuska E Charris
- Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela
| | - Juan R Rodrigues
- Departamento de Tecnología de Procesos Biológicos y Bioquímicos, División de Ciencias Biológicas, Universidad Simón Bolívar, Caracas, Venezuela
| | - Hegira Ramírez
- Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela.,Facultad de Medicina, Universidad de Las Américas, Quito, Ecuador
| | | | - Jorge E Ángel
- Organic Synthesis Laboratory, Design and Pharmacological Evaluation of New Products, Experimental Faculty of Science, Central University of Venezuela, Zulia University, Maracaibo, Venezuela
| | - Jaime E Charris
- Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela
| |
Collapse
|
7
|
Ramírez H, Fernandez E, Rodrigues J, Mayora S, Martínez G, Celis C, De Sanctis JB, Mijares M, Charris J. Synthesis and antimalarial and anticancer evaluation of 7-chlorquinoline-4-thiazoleacetic derivatives containing aryl hydrazide moieties. Arch Pharm (Weinheim) 2021; 354:e2100002. [PMID: 33660349 DOI: 10.1002/ardp.202100002] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2021] [Revised: 02/04/2021] [Accepted: 02/12/2021] [Indexed: 12/23/2022]
Abstract
Twelve 7-chloroquinoline derivatives were designed and synthesized using the principle of molecular hybridization through the coupling of 2-[2-(7-chloroquinolin-4-ylthio)-4-methylthiazol-5-yl]acetic acid 1 with various benzoyl hydrazines 2a-l. The synthetic compounds were tested as antimalarials. Some of them showed an efficient in vitro activity as inhibitors of β-hematin formation and an in vivo activity in a murine model, resulting in compounds 8 and 9 as the most active ones with IC50 values of 0.65 ± 0.09 and 0.64 ± 0.16 µM, respectively. The effects of the compounds on the cell viability, cell cycle, and apoptosis induction of A549 and MCF-7 cancer cell lines were also examined. Our data showed that compounds 6 and 12 were the most active agents, decreasing the cell viability of MCF-7 cells with IC50 values of 15.41 and 12.99 µM, respectively. None of the compounds analyzed significantly affected the viability of peripheral blood mononuclear cells. Also, significant induction of apoptosis was observed when both cancer cell lines were incubated with compounds 6 and 12. In MCF-7 cells, treatment with these compounds led to cell cycle arrest in the G0/G1 phase. The results obtained suggest that these structures may be useful in developing new therapies for malaria and cancer treatment.
Collapse
Affiliation(s)
- Hegira Ramírez
- Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela.,Facultad de Medicina, Universidad de Las Américas, Quito, Ecuador
| | | | - Juan Rodrigues
- Departamento de Tecnología de Procesos Biológicos y Bioquímicos, División de Ciencias Biológicas, Universidad Simón Bolívar, Caracas, Venezuela
| | - Soriuska Mayora
- Biotechnology Unit, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela.,Institute of Immunology, Faculty of Medicine, Central University of Venezuela, Caracas, Venezuela
| | - Gricelis Martínez
- Institute of Immunology, Faculty of Medicine, Central University of Venezuela, Caracas, Venezuela
| | - Carmen Celis
- Biotechnology Unit, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela
| | - Juan B De Sanctis
- Institute of Immunology, Faculty of Medicine, Central University of Venezuela, Caracas, Venezuela.,Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
| | - Michael Mijares
- Biotechnology Unit, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela.,Institute of Immunology, Faculty of Medicine, Central University of Venezuela, Caracas, Venezuela
| | - Jaime Charris
- Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela
| |
Collapse
|
8
|
Rodríguez M, Gutiérrez J, Domínguez J, Peixoto PA, Fernández A, Rodríguez N, Deffieux D, Rojas L, Quideau S, Pouységu L, Charris J. Synthesis and leishmanicidal evaluation of sulfanyl‐ and sulfonyl‐tethered functionalized benzoate derivatives featuring a nitroimidazole moiety. Arch Pharm (Weinheim) 2020; 353:e2000002. [DOI: 10.1002/ardp.202000002] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2020] [Revised: 02/11/2020] [Accepted: 02/13/2020] [Indexed: 12/19/2022]
Affiliation(s)
- Miguel Rodríguez
- Laboratorio de Síntesis Orgánica, Facultad de FarmaciaUniv. Central de Venezuela Caracas Venezuela
| | - Joyce Gutiérrez
- Laboratorio de Síntesis Orgánica, Facultad de FarmaciaUniv. Central de Venezuela Caracas Venezuela
| | - José Domínguez
- Laboratorio de Síntesis Orgánica, Facultad de FarmaciaUniv. Central de Venezuela Caracas Venezuela
| | | | - Alexis Fernández
- Instituto de Biomedicina, Facultad de MedicinaUniv. Central de Venezuela Caracas Venezuela
| | - Noris Rodríguez
- Instituto de Biomedicina, Facultad de MedicinaUniv. Central de Venezuela Caracas Venezuela
| | | | - Luis Rojas
- Laboratorio de Productos Naturales, Facultad de Farmacia y BioanálisisUniv. de Los Andes Mérida Venezuela
| | | | | | - Jaime Charris
- Laboratorio de Síntesis Orgánica, Facultad de FarmaciaUniv. Central de Venezuela Caracas Venezuela
| |
Collapse
|
9
|
Rámirez H, Rodrigues JR, Mijares MR, De Sanctis JB, Charris JE. Synthesis and biological activity of 2-[2-(7-chloroquinolin-4-ylthio)-4-methylthiazol-5-yl]-N-phenylacetamide derivatives as antimalarial and cytotoxic agents. JOURNAL OF CHEMICAL RESEARCH 2020. [DOI: 10.1177/1747519819899073] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
A novel series of 2-[2-(7-chloroquinolin-4-ylthio)-4-methylthiazol-5-yl]- N-phenylacetamide derivatives is synthesized via substitution with 2-mercapto-4-methyl-5-thiazoleacetic acid at position 4 of 4,7-dichloroquinoline to obtain an intermediate acetic acid derivative. The chemical behavior of these reactants was investigated using different reaction conditions to optimize the nucleophilic substitution at position 4. The final compounds are prepared using a modified version of the Steglich esterification reaction between the acetic acid intermediate 3 and different anilines. The structures are confirmed by infrared, 1H, 13C, distortionless enhancement by polarization transfer 135°, Correlated Spectroscopy, heteronuclear correlation spectroscopy and (Long range HETCOR using three BIRD pulses) FLOCK-NMR spectral studies, and by elemental analysis. The synthesized compounds are tested in vitro and in vivo for their potential antimalarial and anticancer activities, with derivative 11 being the most promising candidate.
Collapse
Affiliation(s)
- Hegira Rámirez
- Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela
- Faculty of Medicine, Universidad de las Américas, Quito, Ecuador
| | - Juan R Rodrigues
- Laboratory of Pharmacology and Toxicology, Department of Cell Biology, Simón Bolívar University, Caracas, Venezuela
| | - Michael R Mijares
- Biotechnology Unit, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela
- Institute of Immunology, Faculty of Medicine, Central University of Venezuela, Caracas, Venezuela
| | - Juan B De Sanctis
- Institute of Immunology, Faculty of Medicine, Central University of Venezuela, Caracas, Venezuela
- Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacky University Olomouc, Olomouc, Czech Republic
| | - Jaime E Charris
- Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela
| |
Collapse
|
10
|
Colmenarez C, Acosta M, Rodríguez M, Charris J. Synthesis and antimalarial activity of (S)-methyl-(7-chloroquinolin-4-ylthio)acetamidoalquilate derivatives. JOURNAL OF CHEMICAL RESEARCH 2019. [DOI: 10.1177/1747519819890559] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The synthesis of five new ( S)-methyl-(7-chloroquinolin-4-ylthio)acetamidoalquilate derivatives is carried out under a modified version of the Steglich esterification reaction between different l-amino acid methyl esters and 2-(7-chloroquinolin-4-ylthio)acetic acid. Two of the compounds showed significant inhibition (>50%) of β-hematin formation. The two active structures were tested in vivo as potential antimalarials in mice infected with Plasmodium berghei ANKA, a chloroquine susceptible strain. Compounds 6b and 6e exhibited antimalarial activity comparable to that of chloroquine.
Collapse
Affiliation(s)
- Custodiana Colmenarez
- Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela
| | - María Acosta
- Biochemistry Unit, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela
| | - Miguel Rodríguez
- Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela
| | - Jaime Charris
- Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Caracas, Venezuela
| |
Collapse
|
11
|
Antimalarial, antiproliferative, and apoptotic activity of quinoline-chalcone and quinoline-pyrazoline hybrids. A dual action. Med Chem Res 2019. [DOI: 10.1007/s00044-019-02435-0] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
12
|
Synthesis, antimalarial, antiproliferative, and apoptotic activities of benzimidazole-5-carboxamide derivatives. Med Chem Res 2018. [DOI: 10.1007/s00044-018-2258-x] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
13
|
Optimization of antimalarial, and anticancer activities of ( E )-methyl 2-(7-chloroquinolin-4-ylthio)-3-(4-hydroxyphenyl) acrylate. Bioorg Med Chem 2018; 26:815-823. [DOI: 10.1016/j.bmc.2017.12.022] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2017] [Revised: 12/07/2017] [Accepted: 12/15/2017] [Indexed: 11/17/2022]
|
14
|
Kuzyniak W, Schmidt J, Glac W, Berkholz J, Steinemann G, Hoffmann B, Ermilov EA, Gürek AG, Ahsen V, Nitzsche B, Höpfner M. Novel zinc phthalocyanine as a promising photosensitizer for photodynamic treatment of esophageal cancer. Int J Oncol 2017; 50:953-963. [PMID: 28098886 DOI: 10.3892/ijo.2017.3854] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2016] [Accepted: 12/19/2016] [Indexed: 12/21/2022] Open
Abstract
Photodynamic therapy (PDT) has gathered much attention in the field of cancer treatment and is increasingly used as an alternative solution for esophageal cancer therapy. However, there is a constant need for improving the effectiveness and tolerability of the applied photosensitizers (PS). Here, we propose tetra-triethyleneoxysulfonyl substituted zinc phthalocyanine (ZnPc) as a promising PS for photodynamic treatment of esophageal cancer. ZnPc-induced phototoxicity was studied in two human esophageal cancer cell lines: OE-33 (adenocarcinoma) and Kyse-140 (squamous cell carcinoma). In vitro studies focused on the uptake and intracellular distribution of the novel ZnPc as well as on its growth inhibitory potential, reactive oxygen species (ROS) formation and the induction of apoptosis. The chicken chorioallantoic membrane assay (CAM assay) and studies on native Wistar rats were employed to determine the antineoplastic and antiangiogenic activity of ZnPc-PDT as well as the tolerability and safety of non-photoactivated ZnPc in vivo. ZnPc was taken up by cancer cells in a dose- and time-dependent manner and showed a homogeneous cytoplasmic distribution. Photoactivation of ZnPc-loaded (1-10 µM) cells led to a dose-dependent growth inhibition of esophageal adenocarcinoma and squamous cell carcinoma cells of >90%. The antiproliferative effect was based on ROS-induced cytotoxicity and the induction of mitochondria-driven apoptosis. In vivo studies on esophageal tumor plaques grown on the CAM revealed pronounced antiangiogenic and antineoplastic effects. ZnPc-PDT caused long-lasting changes in the vascular architecture and a marked reduction of tumor feeding blood vessels. Animal studies confirmed the good tolerability and systemic safety of ZnPc, as no changes in immunological, behavioral and organic parameters could be detected upon treatment with the non-photoactivated ZnPc. Our findings show the extraordinary photoactive potential of the novel ZnPc as a photosensitizer for PDT of esophageal cancer.
Collapse
Affiliation(s)
- Weronika Kuzyniak
- Institute of Physiology, Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Jacob Schmidt
- Institute of Physiology, Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Wojciech Glac
- Department of Animal and Human Physiology, Faculty of Biology, University of Gdansk, Gdansk, Poland
| | - Janine Berkholz
- Institute of Physiology, Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Gustav Steinemann
- Institute of Physiology, Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Björn Hoffmann
- Institute of Physiology, Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Eugeny A Ermilov
- Federal Institute for Materials Research and Testing (BAM), Division Biophotonics, Berlin, Germany
| | - Ayşe Gül Gürek
- Department of Chemistry, Gebze Technical University, Gebze, Turkey
| | - Vefa Ahsen
- Department of Chemistry, Gebze Technical University, Gebze, Turkey
| | - Bianca Nitzsche
- Institute of Physiology, Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Michael Höpfner
- Institute of Physiology, Charité-Universitätsmedizin Berlin, Berlin, Germany
| |
Collapse
|
15
|
Lobo G, Monasterios M, Rodrigues J, Gamboa N, Capparelli MV, Martínez-Cuevas J, Lein M, Jung K, Abramjuk C, Charris J. Synthesis, crystal structure and effect of indeno[1,2-b]indole derivatives on prostate cancer in vitro. Potential effect against MMP-9. Eur J Med Chem 2015; 96:281-95. [DOI: 10.1016/j.ejmech.2015.04.023] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2014] [Revised: 04/08/2015] [Accepted: 04/09/2015] [Indexed: 01/03/2023]
|
16
|
Rodrigues JR, Charris J, Camacho J, Barazarte A, Gamboa N, Nitzsche B, Höpfner M, Lein M, Jung K, Abramjuk C. N′-Formyl-2-(5-nitrothiophen-2-yl)benzothiazole-6-carbohydrazide as a potential anti-tumour agent for prostate cancer in experimental studies. J Pharm Pharmacol 2012; 65:411-22. [DOI: 10.1111/j.2042-7158.2012.01607.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2012] [Accepted: 09/21/2012] [Indexed: 12/22/2022]
Abstract
Abstract
Objectives
Benzothiazoles (BZTs) represent organic compounds with different biological actions. In this study we aimed to investigate ten newly synthesized BZT derivatives as potential anti-tumour agents against prostate cancer in vitro and in vivo.
Methods
The cytotoxic effect of these compounds was screened on the human prostate cancer cell lines PC-3 and LNCaP. The most effective compound, N′-formyl-2-(5-nitrothiophen-2-yl)benzothiazole-6-carbohydrazide, was further characterized regarding its dose- and time-dependent effects on cell viability and proliferation (XTT test) as well as on adhesion and spreading (real-time cell analyzer xCelligence), migration (scratch-wound repair assay) and invasion (Boyden chamber) of the cells. This BZT derivative was also tested as an inhibitor of angiogenesis (chicken chorioallantoic membrane assay), clonogenic activity (soft agar) and matrix metalloproteinase 9 (gelatin zymography).
Key findings
N′-Formyl-2-(5-nitrothiophen-2-yl)benzothiazole-6-carbohydrazide significantly inhibited all tested properties of the prostate cancer cell lines and showed low toxic in vitro and in vivo effects. The in vitro anti-tumour activity of this compound was confirmed by the in vivo effects on PC-3 xenografts in nude mice. Tumour growth was decreased in treated compared with untreated mice.
Conclusions
These results suggest the potential capacity of BZTs and in particular N′-formyl-2-(5-nitrothiophen-2-yl)benzothiazole-6-carbohydrazide as anti-tumour agents for the treatment of prostate cancer.
Collapse
Affiliation(s)
- Juan R Rodrigues
- Department of Urology, University Hospital Charité, Berlin, Germany
- Berlin Institute for Urologic Research, Berlin, Germany
| | - Jaime Charris
- Laboratory of Organic Synthesis and Laboratory of Biochemistry, School of Pharmacy, Central University of Venezuela, Caracas, Venezuela
| | - José Camacho
- Laboratory of Organic Synthesis and Laboratory of Biochemistry, School of Pharmacy, Central University of Venezuela, Caracas, Venezuela
| | - Arthur Barazarte
- Laboratory of Organic Synthesis and Laboratory of Biochemistry, School of Pharmacy, Central University of Venezuela, Caracas, Venezuela
| | - Neira Gamboa
- Laboratory of Organic Synthesis and Laboratory of Biochemistry, School of Pharmacy, Central University of Venezuela, Caracas, Venezuela
| | - Bianca Nitzsche
- Berlin Institute for Urologic Research, Berlin, Germany
- Department of Physiology, University Hospital Charité, Berlin, Germany
| | - Michael Höpfner
- Department of Physiology, University Hospital Charité, Berlin, Germany
| | - Michael Lein
- Department of Urology, University Hospital Charité, Berlin, Germany
- Berlin Institute for Urologic Research, Berlin, Germany
- Department of Urology, University Teaching Hospital, Offenbach, Germany
| | - Klaus Jung
- Department of Urology, University Hospital Charité, Berlin, Germany
- Berlin Institute for Urologic Research, Berlin, Germany
| | - Claudia Abramjuk
- Department of Urology, University Hospital Charité, Berlin, Germany
- Berlin Institute for Urologic Research, Berlin, Germany
- Department of Experimental Medicine, University Hospital Charité, Berlin, Germany
| |
Collapse
|
17
|
Rodrigues JR, Ferrer R, Gamboa N, Charris J, Antunes F. Potential antitumour and pro-oxidative effects of (E)-methyl 2-(7-chloroquinolin-4-ylthio)-3-(4-hydroxyphenyl) acrylate (QNACR). J Enzyme Inhib Med Chem 2012; 28:1300-6. [DOI: 10.3109/14756366.2012.736385] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Affiliation(s)
- Juan R. Rodrigues
- Laboratory of Biochemistry of Oxidants and Antioxidants, Centre and Department of Chemistry and Biochemistry, School of Sciences, University of Lisbon,
Lisbon, Portugal
| | - Rosa Ferrer
- Laboratory of Organic Synthesis and Biochemistry, School of Pharmacy, Central University of Venezuela,
Los Chaguaramos, Caracas, Venezuela
| | - Neira Gamboa
- Laboratory of Organic Synthesis and Biochemistry, School of Pharmacy, Central University of Venezuela,
Los Chaguaramos, Caracas, Venezuela
| | - Jaime Charris
- Laboratory of Organic Synthesis and Biochemistry, School of Pharmacy, Central University of Venezuela,
Los Chaguaramos, Caracas, Venezuela
| | - Fernando Antunes
- Laboratory of Biochemistry of Oxidants and Antioxidants, Centre and Department of Chemistry and Biochemistry, School of Sciences, University of Lisbon,
Lisbon, Portugal
| |
Collapse
|